ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharma workplace science funding

Best Places to Work Industry 2013
The Scientist | Jun 1, 2013 | 6 min read
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Samantha Maragh speaks on stage after receiving the State of Maryland Outstanding Young Scientist Award 2019.
Making Standards Exceptional
Meenakshi Prabhune, PhD | Dec 4, 2023 | 9 min read
Samantha Maragh has taken on the difficult challenge of standardizing assays, data norms, and terminology in the ever evolving genome editing field.
Single Nucleotide Polymorphisms: Big Pharma Hedges its Bets
Eugene Russo | Jul 18, 1999 | 7 min read
SNP CENTRAL: A genetics researcher takes to the bench at the Wellcome Trust's Sanger Centre in Cambridge, England. The sequencing center and its London sponsor provided key leadership in the SNP Consortium, a public-private venture to find and map 300,000 single nucleotide polymorphisms. The Wellcome Trust helped entice 10 pharmaceutical firms to join the consortium by putting up $14 million of the project's estimated $45 million price tag. The Sanger Centre will provide much of the radiation h
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
Best Places to Work Academia, 2011
The Scientist | Jul 1, 2011 | 9 min read
Whether it’s attending a Scottish dance party or asking physics buffs to custom build your tools, researchers at this year’s top institutions are getting creative at work.
Life Science Jobs, 2005
Alison McCook(amccook@the-scientist.com) | Dec 19, 2004 | 8 min read
The career outlook for life scientists hit a rocky patch at the start of the 21st century.
When Science Has a Potential Payoff
Karen Pallarito(kpallarito@the-scientist.com) | Jan 16, 2005 | 8 min read
In a recent three-hour session at a Chicago hotel room, the University of Wisconsin's technology transfer office hammered out the final details of licensing deal that granted Durham, NC-based Inspire Pharmaceuticals the right to use several patents to develop glau coma treatments.
Sequencing Stakes: Celera Genomics Carves Its Niche
Ricki Lewis | Jul 18, 1999 | 8 min read
J. Craig Venter is no stranger to contradiction and controversy. He seems to thrive on it. In 1991, when the National Institutes of Health was haggling over patenting expressed sequence tags (ESTs)--a shortcut to identifying protein-encoding genes--Venter the inventor accepted a private offer to found The Institute for Genomic Research (TIGR) in Rockville, Md. TIGR would discover ESTs and give most of them to a commercial sibling, Human Genome Sciences (HGS), to market. ESTs are now a standard
News in a nutshell
Jef Akst | Mar 28, 2010 | 2 min read
More counterfeit newsChinese national Sengyang Zhou was arrested in Hawaii last week on charges of importing and linkurl:selling counterfeit drugs online,;http://www.2daydietshopping.com/ reminiscent of the story of another recently nabbed pharma faker, Kevin Xu, whose downfall is detailed in linkurl:a recent feature;http://www.the-scientist.com/2010/2/1/36/1/ in The Scientist. Image: Wikimedia commons, Tom VarcoZhou's wares included a fake version of the weight-loss pill Alli, and the fakes ar
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019 | 9 min read
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.

Run a Search

ADVERTISEMENT